Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo

Santosh Gupta1, Lyubomyr Lytvynchuk2,3, Taras Ardan4

  • 1Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Summary

Pluripotent stem cell-derived retinal pigment epithelium (pRPE) offers a promising regenerative therapy for retinal diseases like age-related macular degeneration (AMD). This review covers pRPE derivation, transplantation, and challenges in developing functional RPE tissue.